1. Adams R & Murray F. 1978. Improving Your Health
with Vitamin C. Larchmont.
2. Afroz M. 1975. Vitamins C and B. Journal of the American Medical
Association 232:3, 246.
3. Altschule MD. 1976. Is It True What They Say about Cholesterol?
Executive Health 12:no.11.
4. Amato G. 1937. Azione dell'acido ascorbico sul virus fisso della
rabbia e sulla tossina tetanica. Giornale di Batteriologia Virologia
et Immunologia (Torino), vol.19:pp.843-849.
5. Anderson JT, Keys A. 1957. Safflower Oil, Hydrogenated Safflower
Oil and Ascorbic Acid Effects on Serum Cholesterol in Man. Federation
Proceedings (Bethesda), vol.16:p.380.
6. Anderson R. 1982. Effects of Ascorbate on Normal and Abnormal Leukocyte
Functions, in Vitamin C: New Clinical Applications in Immunology. Liped
Metabolism and Cancer, ed. A. Hanck. Hans Huber, Bern, PP.23-34.
7. Anderson R, Lukey PT. 1987. A Biological Role for Ascorbate in the
Selective Neutralization of Extracellular Phagocyte-derived Oxidants.
In: Third Conference on Vitamin C. 1987. Annals of the New York Academy
of Sciences. Vol.498.
8. Baetgen D. Results of the Treatment of Epidemic Hepatitis in Children
with High Doses of Ascorbic Acid in the Years 1957-1958. Medizinische
Monatschrift, vol.15:pp.30-36. 1961.
9.Bailer JC III EM. 1986. Progress Against Cancer. New England J. Medicine
314, 1226-32.
10. Baker III EM. 1971. Ascorbic Sulfate: A Urinary Metabolite of Ascorbic
Acid in Man. Science, vol.173:pp.826-827.
11.Banerjee S. 1944. Part IV. Effect of Vitamin C on the Insulin Content
of the Pancreas of Guinea Pigs. Annals of bio-chemistry and Experimental
Medicine, vol.4:pp.33-36.
12. Banerjee S, Baudyopadhyay A. 1963. Plasma Lipids in Scurvy: Effect
of Ascorbic Acid Supplement and Insulin Treatment. Proceedings Society
Experimental Biology and Medicine, vol.112:pp.372-374.
13. Bartelheimer H. 1939. Vitamin C in the Treatment of Diabetes. Die
Medizinische Welt, vol.13:117-120.
14. Bartlett MK, Jones CM, Ryan AE. 1942. Vitamin C and Wound Healing.
II. Ascorbic Acid Content and Tensile Strength of Healing Wounds in
Human Beings. New England Journal of Medicine 226:474-481.
15. Bates CJ, Mandal AR, Cole TJ. 1977. HDL-Cholesterol and Vitamin
C Status. The Lancet 3:611.
16.Baur H. 1952. Poliomyelitis Therapy with Ascorbic Acid. Helvetia
Medica Acta, Vol. 19:pp.470-474.
17.Baur H, Staub H. 1954. Therapy of Hepatitis with Ascorbic Acid Infusions.
Schweizerische Medizinische Wochenschrift, vol.84:pp.595-597.
18.Becker et al RR. 1953. Ascorbic Acid Deficiency and Cholesterol
Synthesis. Journal American Chemical Society, vol.75:p.2020.
19.Behrens WA, Madere R. A Procedure for the Determination of Ascorbic
and Dehydroascorbic Acid in Biological Fluids, Tissues, and Foods. In:
Third Conference on Vitamin C. 1987. Annals of the New York Academy
of Sciences. Vol.498.
20. Berge GE. 1989. Esterified Polyascorbate: An Alternative for Ailments
in Support and Movement Structure in Dogs.
21. Bingham R. 1984. Fight Back Against Arthritis. Desert Arthritis
Medical Clinic.
22. Biser S. 1989. The Great Vitamin C Myth Exploded. Health Discoveries
Newsletter.
23.Bjelke E. 1974. Epidermological Studies of Cancer of the Stomach,
Colon and Rectum with Special Emphasis on the Role of Diet. Scan J.
Gastro. 9(31) 1-235.
24.Blanchard J, Achari R, Harrison GG and Conrad KA. 1984. The Influence
of Vitamin C on Antipyrine Pharmacokinetics in Elderly Men. Biopharm.
& Drug disp. 5: 43-54.
25.Blanchard J, Hochman D. 1984. Effects of Vitamin C on Caffeine Pharmacokinetics
in Young and Aged Guinea Pigs. Drug-Nutr. Inter. 2: 243-55.
26.Blanchard J, Conrad KA 1988. Comparison of Plasma, Mononuclear and
Polymorphonuclear Leucocyte Vitamin C Levels in Young and Elderly Women
During Depletion and Supplementation. European J. Clin. Nutrition. 43:
97-106.
27.Blanchard J, Conrad KA, Mead KA, Gary PJ. 1989. Vitamin C Disposition
in Young and Elderly Men. Manuscript.
28.Bland J. 1987. The Latest Developments in the Therapy and Biochemistry
of Vitamin C. Seminar Transcript.
29.Bland J. 1989. Reducing the Risk to Coronary Heart Disease: Appraisal
of Progress. In: Nutrition, Health and Peace. Pauling Symposia. Vol
I. Linus Pauling Institute. Jariwalla RJ, Schwoebel SL (eds).
30.Bland J. 1989. The Key to the Power of Vitamin C and its Metabolites.
Keats Publishing.
31.Booker WM et al. 1957. Cholesterol - Ascorbic Acid Relationship.
American J. Phys. 189:335-7.
32.Bordia A. 1980. The Effect of Vitamin C on Blood Lipids, Fibrinolytic
Activity, and Platelet Adhesiveness in Patients with Coronary Artery
Disease. Atherosclerosis 35:2, 181-187.
33.Bradford, Allen & Culbert. 1985. Oxidology. Bradford Foundation.
34. Brandt R, Guyer KE, Banks WL. Jr. 1974. A Simple Method to Prevent
Vitamin C Interference with Urinary Glucose Determinations. Clinica
Chimica Acta 51:103-104.
35. Brighthope I. 1988. The AIDS Fighters. Keats Publishing.
36.Burns, Rivers & Machlin (eds.). 1987. Third Conference on Vitamin
C. Annals of the New York Academy of Sciences. 498.
37.Bush MJ & Verlangieri AJ. 1987. An Acute Study on the Relative
Gastro-Intestinal Absorption of a Novel Form of Calcium Ascorbate. Res.
Comm. Chem Path. Pharm. 57 (1): 137-40.
38.Calabrese EJ, Stoddard A, Leonard DA, Dinardi SR. 1987. The Effects
of Vitamin C Supplementation on Blood and Hair Levels of Cadmium, Lead
and Mercury. In: Third Conference on Vitamin C. Annals of the New York
Academy of Sciences. Vol.498.
39.Calleja HB, Brooks RH. 1960. Acute Hepatitis Treated with High Doses
of Vitamin C. Ohio State Medical Journal, vol.56:pp.821-823.
40.Cameron E, Campbell A. 1974. The Orthomolecular Treatment of Cancer.
II. Clinical Trial of High-Dose Ascorbic Acid Supplements in Advanced
Human Cancer. Chemical-Biological Interactions 9:4, 285-315.
41.Cameron E. 1976. Supplemental Ascorbate in the Supportive Treatment
of Cancer: Prolongation of Survival Times in Terminal Human Cancer.
Proceedings of the National Academy of Sciences 73:10, 3685-3689.
42.Cameron E & Pauling L. 1978. Supplemental Ascorbate in the Supportive
Treatment of Cancer.
43.Cameron E & Pauling L. 1979. Cancer and Vitamin C. Linus Pauling
Institute. Revolution of Prolongation of Survival Times in Terminal
Haaaa Cancer. PNAS 75: 4538-42.
44.Cameron E. 1987. The Vitamin C and Cancer Story: A Personal Perspective.
In: Nutrition, Health and Peace. Pauling Symposia. Vol I. Linus Pauling
Institute. Jariwalla RJ, Schwoebel SL (eds).
45.Castelli WP. 1986. Incidence of Coronary Heart Disease and Lipoprotein
Cholesterol Levels. The Framingham Study. JAMA 256: 2835-38. -1,0
46. Cathcart RF. 1981. Vitamin C Titrating to Bowel Tolerance, Anascorbemia,
and Actue Induced Scurvy. Medical Hypotheses 7: 1359-76.
47. Cathcart RF. 1984. Vitamin C in the Treatment of Acquired Immune
Deficiency Syndrome (AIDS). Medical Hypotheses. 14:423-33.
48. Cathcart RF. 1988. AIDS Treatment Using Ascorbic Acid. Townsend
Letter for Doctors.
49. Cathcart RF. 1989. Letter. Personal Communication.
50. Challem JJ. 1983. Vitamin D Updated. Keats Publishing.
51. Charleston SS & Clegg KM. 1972. Ascorbic Acid and the Common
Cold. The Lancet 1: 140.
52. Cheraskin E, Ringsdorf WM, Jr. 1964. Vitamin C State in a Dental
School Patient Population. Journal of the Southern California State
Dental Association. 32:10, 375-378.
53. Cheraskin E et al. 1968. Effect of Diet Upon Radiation Response
in Cervical Carcinoma & Uterus: A Preliminary Report. Cyptologica
12: 433-438.
54. Cheraskin E, Ringsdorf WM & Sisley E. 1983. The Vitamin C Connection.
Getting well and stayin well with Vitamin C. Harper & Row.
55. Chope HD & Breslow L. 1955. Nutritional Status of the Aging
American. J Public Health 46: 61-7.
56. Choroka PB. 1988. Cancer 1988. Is a Healing Peace in the Government's
War on Cancer Finally at Hand?
57. Cohen AM, Bavly S, Poznanski R. 1961. Change of Diet of Yemenite
Jews in Relation to Diabetes and Ishaemic Heart-Disease. The Lancet
2:1399-1401.
58. Cortinovis et al A. 1960. Ascorbic Acid and Atherosclerosis Giornale
di Gerontologia (Firenze), vol.8:pp.28-31.
59. Cousins N. 1983. The Healing Heart. Norton.
60. Cox MA. 1981. Oxycal vs Arthritis. Ralph Tanner Associates.
61. Creagan et al. 1979. Failure of High-Dose Vitamin C (Ascorbic Acid)
Therapy to Benefit Patients with Advanced Cancer: A Controlled Trial.
New England Journal of Medicine 301:13, 687-690.
62. Dahl H, Degre M. 1976. The Effect of Ascorbic Acid on Production
of Human Interferon and the Antiviral Activity In Vitro. Acta Pathologica
et Microbiologica Scandinavica. 84:5, 280-284.
63. Dainow I. 1943. Treatment of Herpes Zoster with Vitamin C. Dermatologia,
vol.68:pp.197-201.
64. Dalton WL. 1962. Massive Doses of Vitamin C in the Treatment of
Viral Diseases. Journal Indiana State Medical Association, vol.55:pp.1151-1154.
65. Davies S & Stewart A. 1987. Nutritional Medicine. Pan Books.
66. Dawson EB, Harris WA, Rankin WE, Charpentier LA, McGanity WJ. 1987.
Effects of Ascorbic Acid on Male Fertility. In: Third Conference on
Vitamin C. Annals of the New York Academy of Sciences. Vl.498.
67. Deeniham MJ. 1989. Acute Oral Toxicity. Toxicology Laboratory Services,
Northview Pacific Laboratories Inc.
68. Degkwitz E. 1987. Some Effects of Vitamin C May Be Indirect, Since
It Affects the Blood Levels of Cortisol and Thyroid Hormones. In: Third
Conference on Vitamin C. Annals of the New York Academy of Sciences.
Vol.498.
69. Dent et al FM American Journal of Physiology, vol.163:p.700.1950.
70. Di Fabio A. 1982. Rheumatoid Diseases Cured at Last. Rheumatoid
Disease Foundation.
71. Di Fabio A. 1988. The Art of Getting Well. Rheumatoid Disease Foundation.
72. Diliberto EJ Jr, Menniti FS, Knoth J, Daniels AJ, Kizer JS, Viveros
OH. Adrenomedullary Chromaffin Cells as a Model to Study the Neurobiology
of Ascorbic Acid: From Monooxygenation to Neuromodulation. In: Third
Conference on Vitamin C. 1987. Annals of the New York Academy of Sciences.
Vol.498.
73. Dokter CE. 1983. Clinical Evaluation.
74. Erasmus U. 1986. Fats and Oils, the Complete Guide to Fats and
Oils in Health and Nutrition. 1986 Alive Books Publishing.
75. Erasmus U. 1988. Fats that Heal Fats that Kill. Lecture. Cancer
Control Society Convention.
76. Evans W. 1938. Vitamin C in Heart Failure. Lancet, vol.1:pp.308-309.
77. Federova EP. 1960. Long Term Ascorbic Acid Therapy for Patients
with Coronary Atherosclerosis. Sovetskaia Meditsiana (Moskva), vol.25:pp.56-60.
78. Fidanza A, Audisio M, Mastroiacovo P. 1982. Vitamin C and Cholesterol,
in Vitamin C: New Clinical Applications in Immunology, Lipid Metabolism,
and Cancer, ed. A. Hanck. Hans Huber, Bern,pp.153-171.
79. Free V, Sanders P. 1978. The Use of Ascorbic Acid and Mineral Supplements
in the Detoxification of Narcotic Addicts. Journal of Orthomolecular
Psychiatry 7:4, 264-270.
80. Furth A & Harding J. 1989. Why Sugar is Bad for You. New Scientist.
23 Sept., 44-7.
81. Gale ET, Thewlis MW. 1953. Vitamin C and P in Cardiovascular and
Cerebrovascular Disease. Geriatrics, vol.8:pp.80-87.
82. Gey KF, Stahelin HB, Evans A. Relationship of Plasma Level of Vitamin
C to Mortality from Ischmic Heart Disease. In: Third Conference on Vitamin
C. 1987. Annals of the New York Academy of Sciences. Vol.498.
83. Ginter et al E. 1969. The Effect of Chronic Hypovitaminosis C on
the Metabolism of Cholesterol and Atherogenesis in Guinea Pigs. Journal
of Atherosclerosis Research, vol. 10; pp.341-352.
84. Ginter E. 1973. Cholesterol: Vitamin C Controls Its Transformation
to Bile Acids. Science 179:74, 702-704.
85. Ginter E et al. 1977. `Effects of Ascorbic Acid on Plasma Cholesterol
in Humans in a Long-Term Experiment.' International Journal of Vitamin
Nutrition Research 47(2):123-134.
86. Ginter E. 1980. The Role of Vitamin C in Lipid Metabolism. Presented
at a symposium entitled `Vitamin C-Its Pharmacologic Activity and Nutritional
Aspects,' Mexico City, Mexico, National Commission of Fruiticulture.
87. Ginter E. 1982. Vitamin C in the Control of Hypercholesteremia
in Man, in Vitamin C: New Clinical Applications in Immunolgy, Lipid
Metabolism, and Cancer, ed. A. Hanck. Hans Huber, Bern, pp.137-152.
88. Ginter E, Jurcovincova M. Chronic Vitamin C Deficiency Lowers Fractional
Catabolic Rate of Low-Density Lipoproteins in Guinea Pigs. In: Third
Conference on Vitamin C. 1987. Annals of the New York Academy of Sciences.
Vol.498.
89. Gkembotski CC. The Role of Ascorbic Acid in the Biosynthesis of
the Neuroendocrine Peptides a-MSHd TRH. In: Third Conference on Vitamin
C. 1987. Annals of the New york Academy of Sciences. Vol. 498.
90. Goertz E. 1986. Clinical Data on Ester-C. Report on 20 Cases.
91. Graham J & Odent M. 1986. The Z. Factor. How Zinc is Vital
to Your Health. Thorsons.
92. Greer E. 1955. Vitamin C in Acute Poliomyelitis. Medical Times
(Manhasset), vol.83:pp.1160-1161.
93. Griffith HW. 1988. Complete Guide to Vitamins Minerals & Supplements.
Fisher.
94. Gsell O, Kalt F. 1954. Treatment of Epidemic Poliomyelitis with
High Doses of Ascorbic Acid. Schweizerische Medizinische Wochenschrift,
vol.84:pp.661-666.
95. Haid H. 1941. Vitamin C in Blood in Insulin Shock. Zeitschrift
fur Klinische Medizin, vol.139:p.485.
96. Hallberg L, Brune M, Rossander-Hulthen L. Is There a Physiological
Role of Vitamin C in Iron Absorption. In: Third Conference on Vitamin
C. 1987. Annals of the New York Academy of Sciences. Vol.498.
97. Harakeh S & Jariwalla RJ. 1989. Suppression of HIV Replication
and Virus Infectivity In Vitro By Ascorbate. Manuscript. Submitted.
98.Harris A, Robinson AB, Pauling L. 1973. Blood Plasma L-Ascorbic
Acid Concentration for Oral L-Ascorbic Acid Dosage up to 12 Grams per
Day. International Research Communications System, page 19, December.
99. Hausman P. 1987. The Right Dose. How to Take Vitamins & Minerals
Safely. Rodale Press.
100. Hay LL. 1984. You Can Heal Your Life. Eden Grove.
101. Heikkila RE, Manzino L. Ascorbic Acid, Redox Cycling, Lipid Peroxidation
and the Binding of Dopamine Receptor Antagonists. In: Third Conference
on Vitamin C. 1987. Annals of the New York Academy of Sciences. Vol.498.
102. Herbert V, Jacob E. 1974. Destruction of Vitamin B by Ascorbic
Acid. Journal of the American Medical Association 230:241-242.
103. Hogenkamp HPC. 1980. The Interaction Between Vitamin B and Vitamin
C. The American Journal of Clinical Nutrition 33:1, 1-3.
104. Holden M, Resnick RJ. 1936. In Vitro Action of Synthetic Crystalline
Vitamin C (Ascorbic Acid) on Herpes Virus. Journel of Immunology, vol.31:pp.455-462.
105. Holden M, Molloy E. 1937. Further Experiments on Inactivation
of Herpes by Vitamin C (1-ascorbic acid). Ibid., vol.33:pp.251-257.
106. Hornig G, Weiser H, Weber F & Wiss (O). 1973. Effect of massive
Doses of Ascorbic Acid on its Catabolism & Guinea Pigs. Inter. J.
Vit. & Nutrition Res 43(1) 28-33.
107. Hornig D. Recent advances in Vitamin C Metabolism. 1974. In: Second
Conferemce on Vitamin C. Annals of the New York Academy of Science,
91-103.
108. Horrobin DF, Manku MS, Oka M, Morgan RO, Cunnane SC, Ally AI,
Ghayur T, Schweitzer M, Karmaki RA. 1979. The Nutritional Regulation
of T Lymphocyte Function. Medical Hypotheses 5:969-985.
109. Horrobin DF, Oka M, Manku MS. 1979. The Regulation of Prostaglandin
E1 Formation: A Candidate for One of the Fundamental Mechanisms Involved
in the Actions of Vitamin C. Medical Hypotheses 5:849-858.
110. Houston RG. 1987. Repression and Reform in the Evaluation of Alternative
Cancer Therapies. 1987.
111. Hume & Weyers E. 1973. Changes in Leucocyte Ascorbic Acid
during the Common Cold. Scottish Medical J. 18, 3-7.
112. Ibric LLV, Sevanian A. Effects of Ascorbic and Dehydroascorbic
Acids on lipid Composition of C H/1OT Cells. In: Third Conference on
Vitamin C. 1987. Annals of the New York Academy of Sciences. Vol.498.
113. Jacob RA, Omaye ST, Skala JH, Leggott PJ, Rothman DL, Murray PA.
Experimental Vitamin C Depletion and Supplementation in Young Men: In:
Third Conference on Vitamin C. 1987. Annals of the New York Academy
of Sciences. Vol.498.
114. Jaffe RM, Kasten B, Young DS, MacLowry JD. 1975. False-Negative
Stool Occult Blood Tests Caused by Ingestion of Ascorbic Acid (Vitamin
C). Annals of Intenal Medicine 83:6, 824-826.
115. Jaffe RM, Lawrence L, Schmid A, MacLowry JD 1979. Inhibition by
Ascorbic Acid (Vitamin C) of Chemical Detection of Blood in Urine. American
Journal of Clinical Pathology 72:3, 468-470.
116. Jaffe RM, Zierdt W. 1979. A New Occult Blood Test Not Subject
to False-Negative Results from Reducing Substances. Journal of Laboratory
and Clinical Medicine 93:5, 879-886.
117. Jariwalla RJ, Schwoebel SL (eds). 1987. Nutrition, Health and
Peace. Pauling Symposia. Vol I. Linus Pauling Institute.
118. Johnson GE, Obenshain SS. 1981. Nonresponsiveness of Serum High-Density
Lipoprotein-Cholesterol to High Dose Ascorbic Acid Administration in
Normal Men. American Journal of Clinical Nutrition 34:2088-2091.
119. Jungeblut CW. 1935. Inactivation of Poliomyelitis Virus by Crystalline
Vitamin C (Ascorbic Acid). Journal of Experimental Medicine, vol.62:pp.
517-521.
120. Jungeblut CW. 1939. Further Observations on Vitamin C Therapy
in Experimental Poliomyelitis. Journal of Experimental Medicine, vol.65:
pp.127-146. 1937. Ibid., vol.66:pp.459-477, 1937. Ibid., vol.70:pp.315-332.
121. Jungeblut, CW. A Further Contribution to the Vitamin C Therapy
in Experimental Poliomyelitis. Journal of Experimental Medicine, vol
70: p.327. 1939.
12. Kallner A. Requirement for Vitamin C Based on Metabolic Studies.
In: Third Conference on Vitamin C. 1987. Annals of the New York Academy
of Sciences. Vol.498.
123. Kapeghian JC & Verlangieri AJ. 1984. The Effects of Glucose
on Ascorbic Acid Uptake in Heart Endothelial Cells: Possible Pathogenesis
of Diabetic Angiopathies. Life Sciences, 34: 577-84.
124. Katz SM, DiSilvio TV. 1973. Ascorbic Acid Effects on Serum Glucose
Values. Journal of the American Medical Association 224:5, 628.
125. Kirchmair H. 1957. Treatment of Epidemic Hepatitis in Children
with High Doses of Ascorbic Acid. Medizinische Monatschrift, vol. 11:pp.
353-357. 1957. Epidemic Hepatitis in Children. Deutsche Gesundheitwesen,
vol.12:pp.773-774. 1957. Epidemic Hepatitis in Children and Its Treatment
with High Doses of Ascorbic Acid. Ibid., vol. 12: pp. 1525-1536. 1957.
126. Klenner FR. 1948. Virus Pneumonia and Its Treatment with Vitamin
C. Southern Medicine and Surgery, vol.110: pp.34-46.
127. Klenner FR. The Treatment of Poliomyelitis and Other Virus Diseases
with Vitamin C. Southern Medicine and Surgery, vol. 111: pp. 209-214.
1949. Massive Doses of Vitamin C and the Virus Diseases. Ibid., vol.
113: pp. 101-107. 1951. The Vitamin and Massage Treatment for Acute
Poliomyelitis. Ibid., vol. 114: pp. 194-197. 1952. The Use of Vitamin
C as an Antibiotic. Journal of Applied Nutrition, vol 6: pp. 274-278.
1953. The Folly in the Continued Use of a Killed Polio Virus Vaccine.
Tri-State Medical Journal, pp. 1-8. Feb. 1959.
128. Klenner FR. 1951. Massive Doses of Vitamin C and the Viral Diseases.
Southern Medicine and Surgery 113:101-107.
129. Klenner FR. 1971. Observations on the Dose and Administration
of Ascorbic Acid When Employed Beyond the Range of a Vitamin in Human
Pathology. Journal of Applied Nutrition 23:3-4, 61-88.
130. Kligler IJ, Bernkopf H. 1937. Inactivation of Vaccinia Virus by
Ascorbic Acid and Glutathione. Nature, vol. 139:pp.965-966.
131. Kolmakov VN 1957. Effect of Vitamin C on Hypercholesterolmia in
Fasting Rabbits. Voprosy Meditsinskoi Khimii (Moskva), vol.3:pp.414-419.
132. Lamden MP, Chrystowski GA. 1954. Urinary Oxalate Excretion by
Man Following Ascorbic Acid Ingestion. Proceedings of the Society for
Experimental Biology and Medicine 85:190-192.
133. Langenbusch W, Enderling A. 1937. Einfluss der Vitamine auf das
Virus der Maul-und Klavenseuch. Zentralblatt fur Bakteriologie, vol.140:pp.112-115.
134. Lee W, Davis KA, Rettmer LR, Labbe RF. 1988. Ascorbic Acid Status:
Biochemical and Clinical Considerations. Am J. Clin. Nutr. 48: 286-90.
135. Leibovitz B. 1984. Carnitine: The Vitamin B Phenomenon. Dell,
New York.
136. Levine M & Morita K. 1985. Ascorbic Acid in Endocrine systems.
In: Vitamins and Hormones. Vol 42. Academic Press.
137. Levine M, Morita K, Heldman & Pollard HB. 1985. Ascorbic Acid
Regulation of Norephinephrine Biosynthesis in Isolated Chromaffin Granules
from Bovine Adrenal Medulla. J. Biol. Chem.. 260 (29): 15598-15603.
138. Levine M. 1986. New Concepts in the Biology and Biochemistry of
Ascorbic Acid. The New England Journal of Medicine Vol. 314 No. 14:
892-902.
139. Levine M. 1986. Ascorbic Acid Specifically Enhances Dopamine Monooxygenase
Activity in Resting and Stimulated Chromaffin Cells. J. Biol. Chem.
261(16): 7347-56.
140. Levine M, Hartzell W. 1987. Ascorbic Acid: The Concept of Optimum
Requirements. In: Third Conference on Vitamin C. 1987. Annals of the
New York Academy of Sciences. Vol.498.
141. Lohmann W. Ascorbic Acid and Cancer. In: Third Conference on Vitamin
C. 1987. Annals of the New York Academy of Sciences. Vol.498.
142. Lojkin M. 1936. Contributions of the Boyce Thompson Institute,
vol.8, No.4. LF Martin. Proceedings Third International Congress of
Microbiology, New York, 1940, p.281.
143. Lominski I. 1936. Inactivation du bacteriophage par l'acide ascorbique.
Comptes Rendus des Seances de la Societe de Biologie et de Ses Filliales
(Paris),vol.122:pp.766-768.
144. Marcus M, Prabhudesai M, Wassef S. 1980. Stability of Vitamin
B in the Presence of Ascorbic Acid in Food and Serum: Restoration by
Cyanide of Apparent Loss. American Journal of Clinical Nutrition 33:137-143.
145. Marcus, M. 1981. `Vitamin B12: Response to Dr. Herbert.' The American
Journal of Clinical Nutrition 34:1622-1624.
146. Markham RG. 1989. Compositions and Methods for Administering Vitamin
C. United States Patent No. 4,822,816.
147. Martin S & Chaitow L. 1988. A World Without Aids. Thorsons.
148. Mayson JS, Schumaker O, Nakamura RM. 1972. False-Negative Tests
for Urinary Glucose in the Presence of Ascorbic Acid. American Journal
of Clinical Pathology 58:3, 297-299.
149. McCormick WJ. 1957. Coronary Thrombosis. A New Concept of Mechanism
and Etiology. Clinical Medicine, pp.839-845.
150. Melethil S, Subrahmanyam MB, Chang CJ, Mason WD. Megadoses of
Vitamin C: A Pharmacokinetic Evaluation. In: Third Conference on Vitamin
C. 1987. Annals of the New York Academy of Sciences. Vol.498.
151. Menten ML, King CG. 1935. The Influence of Vitamin C Level upon
Resistance to Diptheria Toxin. Journal of Nutrition. vol.10:pp.141-153.
152. Milner JE. 1980. Ascorbic Acid in the Prevention of Chromium Dermatitis.
Journal of Occupational Medicine 22:1, 51-52.
153. Moertel CG, Fleming TR, Creagan ET, Rubin J, O'Connell MJ, Ames
MM. 1985. High-Dose Vitamin C versus Placebo in the Treatment of Patients
with Advanced Cancer Who Had No Prior Chemotherapy. New England Journal
of Medicine 312:137-141.
154. Morishige F, Murata A. Prolongation of Survival Times in Terminal
Human Cancer by Administration of Supplemental Ascorbate. Journal of
the International Academy of Preventive Medicine 5:1, 47-52, 1978.
155. Morishige F, Murata A. 1978. Vitamin C for Prophylaxis of Viral
Hepatitis B in Transfused Patients. Journal of the International Academy
of Preventive Medicine 5:54-58.
156. Mueller L. 1989. Dysplasia's End. Outdoor Life. April.
157. Mumma RO. 1968. Ascorbic Acid as a Sulfating Agent. Biochimica
et Biophysica Acta, vol.165:pp.571-573. Mumma RO, Verlangieri AJ. 1971.
In Vivo Sulfation of Cholesterol by Ascorbic Acid 3-Sulfate as a Possible
Explanation for the Hypocholestemic Effects of Ascorbic Acid. Federation
Proceedings, vol.30, No.2.
158. Murata A. 1975. Virucidal Activity of Vitamin C: Vitamin C for
Prevention and Treatment of Viral Diseases. Proceedings of the First
Intersectional Congress of Microbiological Societies, Science Council
of Japan 3:432-442.
159. Nahata MC, McLeod. 1978. Noneffect of Oral Ascorbic Acid on Urinary
Copper Reduction Glucose Test. Diabetes Care 1:1, 34-35.
160. Newmark HL, 1976. Stability of Vitamin B in the Presence of Ascorbic
Acid. American Journal of Clinical Nutrition 29:6, 645-649.
161. Niki E. Interaction of Ascorbate and a-Tocopherol. In: Third Conference
on Vitamin C. 1987. Annals of the New York Academy of Sciences. Vol.498.
162. Omaye ST, Schaus EE, Kutnink MA, Hawkes WC. Measurement of Vitamin
C in Blood Components by High-Performance Liquid Chromatography: Implication
in Assessing Vitamin C Status. In: Third Conference on Vitamin C. 1987.
Annals of the New York Academy of Sciences. Vol.498.
163. Paez de la Torre JM. 1945. Ascorbic Acid in Measles. Archives
Argentinos do Pediatria, vol.24:pp.225-227. Paterson JC. 1941. Some
Factors in the Causation of Intimal Hemorrhages and in the Precipitation
of Coronary Thrombi. Canadian Medical Association Journal, vol. 44:
pp.114-120.
164. Pauling L. 1970. Vitamin C the Common Cold & the Flu. Berkley.
165. Pauling L. et al. 1985. Effect of Ascorbic Acid on the Incidence
of Spontaneous Mammary Tumors in RIII PNAS 82:5185-89
166. Pauling L. 1986. How to Live Longer and Feel Better. Avon Books.
167. Pecoraro RE, Chen MS. Ascorbic Acid Metabolism in Diabetes Mellitus.
In: Third Conference on Vitamin C. 1987. Annals of the New York Acadamy
of Sciences. Vol.498.
168. Pfeiffer CC. 1987. Mental illness and Schizophrenia. The Nutrition
Connection. Thorsons.
169. Pfleger R, Scholl F. 1937. Diabetes and Vitamin C. Wiener Archiv
fur Innere Medizin, vol.31:PP.219-229.
170. Prauer, HW 1971. Vitamin C and Tests for Diabetes. New England
Journal of Medicine 284:23, 1328.
171. Prinz Wetal. 1977. The Effect of Ascorbic Acid Supplementation
on Some Parameters of Human Immunological Defence System. Int. J. Vit.
& Nut. Research 47, 248-56.
172. Project, Cure Center for Alternative Cancer Research. 2020 K Street
NW Suite 350, Washington DC 20069. (202) 293-3479.
173. Richards RK, Kueter D, Klatt TJ. 1941. Effect of Vitamin C deficiency
on different types of barbiturates. Proc. Soc. Exp. Biol. Med. 48: 403-9.
174. Rineheart JF, Mettier SR. 1934. The Heart Valves and Muscle in
Experimental Scurvy with Superimposed Infection. American Journal of
Pathology. vol.10: pp.61-79.
175. Ringsdorf WM, JR, Cheraskin E. 1978. Lingual Ascorbic Acid Test.
Quintessence International 12:1707, 81-85.
176. Ringsdorf WM, Jr, Cheraskin E. 1979. Vitamin C and the Metabolism
of Analgesic, Antipyretic, and Anti-Inflammatory Drugs: A Review. Alabama
Journal of Medical Sciences. 16:3, 217-220.
177. Ringsdorf WM Jr, Cheraskin E. 1982. Vitamin C and Human Wound
Healing. Oral Surgery 53:231-236.
178. Rivers JM. Safety of High-level Vitamin C Ingestion. In: Third
Conference on Vitamin C.1987. Annals of the New York Academy of Sciences.
Vol.498.
179. Recommended Dietary Allowances. National Academy of Sciences.
Washington. Nat. Acad. Press 19?? p7-75.
180. Rogoff et al JM. 1944. Vitamin C and Insulin Action. Pennsylvania
Medical Journal, vol.47:pp.579-582.
181. Romney SL, Basu J, Vermund S, Palen PR, Duttagupta C. Plasma Reduced
and Total Ascorbic Acid in Human Uterine Cervix Dysplasiaas and Cancer.
In: Third Conference on Vitamin C. 1987. Annals of the New York Academy
of Sciences. Vol.498.
182. Rose RC. Ascorbic Acid Protection against Free Radicals. In: Third
Conference on Vitamin C. 1987. Annals of the New York Academy of Sciences.
Vol.498.
183. Rossander L, Hallberg L, Bjorn-Rasmussen E. 1979. Absorption of
Iron from Breakfast Meals. American Journal of Clinical Nutrition 32:12,
2484-2489.
184. Ruskin SL. 1952. Crystalline Calcium Ascorbate and Methods of
Preparing Same. United States Patent Office No. 2,596,103.
185. Sabin AB. Vitamin C in Relation to Experimental Poliomyelitis,
Journal of Experimental Medicine, vol. 69: pp.507-515. 1939.
186. Samitz MH. 1970. Ascorbic Acid in the Prevention and Treatment
of Toxic Effects of Chromates. Acta Dermatovenereologica 50:1, 59-64.
187. Scher J. Vitamin C as an Adjunct in Methadone Maintenance and
Detoxification of Narcotic Addicts. Journal of Orthomolecular Psychiatry
5:3, 191-198.
188. Schmidt, Karl-Heinz et al. 1981. `Urinary Oxalate Excretion After
Large Intakes of Ascorbic Acid in Man.' The American Journal of Clinical
Nutrition 34:305-311.
189. Sebrov KR. 1956. Prophylaxis and Treatment of Arteriosclerosis
with Ascorbic Acid. Terapevticheskii Arkhiv (Moskva), vol.28:pp.55-65
190. Shaffer CF. 1970. Ascorbic Acid and Atherosclerosis. American
Journal of Clinical Nutrition, vol.23:pp.27-30.
191. Sigal A, King CG. 1936. The Relationship of Vitamin C to Glucose
Tolerance in the Guinea Pig. Journal of Biological Chemistry, vol.116:pp.489-492.
192. Smith JL, Hodges RE. Serum Levels of Vitamin C in Relation to
Dietry and Supplemental Intake of Vitamin C in Smokers and Nonsmokers.
In: Third Conference on Vitamin C. 1987. Annals of the New York Academy
of Sciences. Vol.498.
193. Sokoloff et al B. 1967. Effect of Ascorbic Acid on Certain Blood
Fat Metabolism Factors in Animals and Man. Journal of Nutrition, vol.91:pp.107-118.
194. Spiegel HE & Pinili E. 1974. Effect of Vitamin C on SGOT,
SGPT, LDH & Bilirubin. Med. J. of Aus 2(7) 265-6.
195. Spittle CR. 1971. Atherosclerosis and Vitamin C. The Lancet 2:1280-1281.
196. Spittle CR. 1974. The Action of Vitamin C on Blood Vessels. American
Heart Journal 88:3, 387-388.
197. Stahelin HB, Gey KF, Brubacher G. Plasma Vitamin C and Cancer
Death: The Prospective Basel Study. In: Third Conference on Vitamin
C. 1987. Annals of the New York Academy of Sciences. Vol.498.
198. Stewart et al CT. 1952. Factors Determining Effect of Insulin
on Metabolism of Glucose in Ascorbic Acid Deficiency and Scurvy in the
Monkey. American Journal of Diseases of Children, vol.84:pp.677-690.
199. Stone I. 1965. Studies of a Mammalian Enzyme System for Producing
Evolutionary Evidence. Mon. Amer. J. Physical Arthrop. 23: 83-86.
200. Stone I. 1972. The Healing Factor: Vitamin C against Disease.
Grosset & Dunlap.
201. Stone N, Meister A. 1962. Function of Ascorbic Acid in the Conversion
of the Proline to Collagen Hydroxyproline. Nature, vol.194:p.555.
202. Szent-Gyorgyi A. 1937. Studies on Biological Oxidation and Some
of Its Catalysts. Szeged, Hungary.
203. Tajima S, Pinnell SR. 1982. Regulations of Collagen Synthesis
by Ascorbic Acid: Asorbic Acid Increases Type I Procollagen mRNA. Biochemical
and Biophysical Research Communications 106:632-637.
204. Tannenbaum ST, Wishnok JS. Inhibition of Nitrosamine Formation
by Ascorbic Acid. In: Third Conference on Vitamin C. 1987. Annals of
the New York Academy of Sciences. Vol.498.
205. Taylor S. 1937. Scurvy and Carditis. Lancet, vol. 1: pp.973-979.
206. Thomas CB, Holljes HWD, Eisenberg FF. 1961. Observations on Seasonal
Variations in Total Serum Cholesterol Level Among Healthy Young Prisoners.
Annals of Internal Medicine 54:3, 413-430.
207. Thomas M, Hughes RE. 1985. `Evaluation of Threonic Acid Toxicity
in Small Animals,' Food Chemistry 17:79-83.
208. Thomas WR, Holt RG. 1978. `Vitamin C and Immunity: An Assessment
of the Evidence.' Clinical Experimental Immunology 32:370-379.
209. Tiapina LA. 1961. The Effect of Ascorbic Acid on Blood Lipids
in Essential Hypertension and Atherosclerosis. Cor et Vasa (Praha),
vol.3:pp.98-106.
210. Trang JM, Blanchard J, 1982. The Effect of Vitamin C on the Pharmacokinetics
of caffeine in Elderly Men. Amer. J. Clin. Nutri. 35: 487-94.
211. Trimmer RW, Lundy CJ. 1948. A Nutrition Survey in Heart Desease.
American Practitioner, vol.2: pp.448-450.
212. TSAO, CS. SALIMI, SL. PAULING, L 1982. Lack of Effect of Ascorbic
Acid on Calcium Excretion. IRCS Medical Science 10:738.
213. TSAO, C. SALIMI, S. L. (1984) Effects of Large Intake of Ascorbic
Acid on Urinary and Plasma Oxalic Acid Levels. International Journal
of Nutrition and Vitamin Research 54:245-249.
214. TSAO, CS. SALIMI, SL. 1984. Evidence of Rebound Effect with Ascorbic
Acid. Medical Hypotheses 13:303-310.
215. Turley SD, West CE, Horton BJ. 1976. The Role of Ascorbic Acid
in the Regulation of Cholesterol Metabolism and in the pathogenesis
of Atherosclerosis. Atherosclerosis 24:1-18.
216. Uverskaia VT. 1958. Influence of Ascorbic Acid on Cholesterolemia
and Acid-Base Balance in Patients with Hypertensive Disease and Atherosclerosis.
Trudy Leningradskogo Sanitarnogigienicheskogo Meditsinskego Instituta,
vol.40:pp.150-158.
217. Vallance S. (1977). Relationships between Ascorbic Acid and Serum
Proteins of the Immune System. British Medical Journal 2, 437-438.
218. Vargus Magne R. 1963. Vitamin C in Treatment of Influenza. El
Dia Medico, vol.35:pp.1714-1715.
219. Verlangieri AJ. 1973. Possible Biological & Pharmacological
Significance of L-Ascorbic Acid & L-Ascorbic Acid z-Sulphate on
Chol???? Metabolism, Metabolic Sulfation and Atherogeneses. 1973. Ph.
D. Thesis. Penn. State Univ.
220. Verlangieri AJ & Stevens JW. 1979. L-Ascorbic Acid: Efects
on Aortic Glycosaminoglycan S Incorporated in Rabbit Induced Atherogenesis
Blood Vessels. 16(4): 177-85.
221. Verlangieri AJ & Sestito J. 1981. Effect of Insulin on Ascorbic
Acid Uptake by Heart Endothelial Cells: Possible Relationship to Retinal
Atherogeneses. Life Sciences 29, 5-9.
222. Verlangieri AJ. Bush MJ & Kapeghian. 1984. Duplex Ultrasound
Analysis of the Carotid Arteries in Macaca Fascicularis. J. Card. Ultrason.
Vol. 2 (4): 293-302.
223. Verlangieri AJ. 1985. The Role of Vitamin C in Diabetic and Nondiabetic
Atherosclerosis. Bulletin, Bureay of Pharm. Services. Univ. Miss. Vol
21.
224. Verlangieri AJ. Cardin BA & Bush M. 1985. The Interaction
of Aortic Glycosaminoglycans and -Inulin Endothelial Permeability in
Cholesterol Induced Rabbit Atherogenesis.
225. Verlangieri AJ. 1987. Acute Study to Determine the Relative Gastro-Intestinal
Absorption of Ester C as Compared to L-Ascorbic Acid.
226. Verlangieri AJ. 1988. Acute study to Determine the Relative Rate
of Absorption and Excretion of Ester-C Calcium Ascorbate, USP Calcium
Ascorbate with an added Metabolite and `Another Commercial Ascorbate'.
227. Verlangieri AJ. Acute Study to determine the Relative Rate of
Absorption and Excretion of Ester C, Calcium Ascorbate, Calcium Ascorbate
and Calcium Threorate and Relative Vitamin C.
228. Verlangieri AJ. 1988. Acute Study to Determine the Relative Rate
of Absorption and Excretion of USP Calcium Ascorbate and Ester-C Calcium
Ascorbate.
229. Verlangieri AJ. 1989. The Effect of Calcium-L-Threonate on the
Uptake of C-L-Ascorbic Acid into 3T3 Mouse Fibroblasts.
230. Verlangieri AJ. 1989. Effects of Vitamin C and Vitamin E on Induced
Primate Atherosclerosis. Manuscripted submitted.
231. Wapnick AA. 1969. The Effect of Ascorbic Acid Deficiency on Desferrioxamine-Induced
Urinary Iron Excretion. British Journal of Haematology 17:6, 563-568.
232. Wassertheil-Smoller S. 1981. Dietary Vitamin C and Uterine Cervical
Dysplasia. American Journal of Epidemiology 114:5, 714-724.
233. Waugh WA, King CG. 1932. Isolation and Identification of Vitamin
C. Journal of Biological Chemistry 97:325-331.
234. Werbach MR. 1987. Nutritional Influences on Illoscases. Thorsons.
235. Willis GC. 1953. An Experimental Study of the Intimal Hemorrhages
and in the Precipitation of Coronary Thrombi. Canadian Medical Association
Journal, vol.69:pp.17-22.
236. Willis et al GC. 1954. Serial Arteriography in Atherosclerosis.
Canadian Medical Association Journal, vol. 71: pp.562-568.
237. Willis GC, Fishman S. 1955. Ascorbic Acid Content of Human Arterial
Tissue. Canadian Medical Association Journal, vol.72:pp.500-503.
238. Willis GC. 1957. The Influence of Ascorbic Acid upon the Liver.
Canadian Medical Association Journal, vol.76:pp.1044-1048.
239. Willis GC. 1957. The Reversibility of Atherosclerosis. Canadian
Medical Association Journal of Nutrition, vol.77:pp.106-109.
240. Wilson, PW, Garrison RJ, 1980. Prevalence of Coronary Heart Disease
in the Framingham Offspring Study: Role of Lipoprotein Cholesterol.
Am. J. Cardio. 46: 649-54.
241. Wright JV & Suen RM. 1987. A Clinical Study of Ester-C vs
L-Ascorbic Acid. Meridian Valley Clinical Laboratory.
242. Yonemoto RH, Chretien PB, Fehniger TF. 1976. Enhanced Lymphocyte
Blastogenesis by Oral Ascorbic Acid. Proceedings of the American Association
for Cancer Research 17:288.
243. Yudkin J, Edelman I, Hough L, (EDS.) 1971. Sugar: Chemical, Biological,
and Nutritional Aspects of Sucrose. Daniel Davey, Hartford, Conn.
244. Yudkin J. 1972. Sweet and Dangerous. Peter H. Wyden, New York.
245. Zannoni VG, Brodfuehrer JI, Smart RC, Susick Jr RL. Ascorbic Acid,
Alcohol, and Environmental Chemicals. In: Third Conference on Vitamin
C. 1987. Annals of the New York Academy of Sciences. Vol.498.
246. Zureick M. 1950. Treatment of Shingles and Herpes with Vitamin
C Intravenously. Journal des Praticiens, vol.64: p.586.
Vitamn C - The Master Nutrient
